OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · Real-Time Price · USD
1.580
0.00 (0.00%)
At close: Apr 28, 2026, 4:00 PM EDT
1.550
-0.030 (-1.90%)
After-hours: Apr 28, 2026, 4:55 PM EDT
OKYO Pharma Market Cap
OKYO Pharma has a market cap or net worth of $82.92 million as of April 28, 2026. Its market cap has increased by 128.35% in one year.
Market Cap
82.92M
Enterprise Value
79.41M
1-Year Change
128.35%
Ranking
Category
Stock Price
$1.58
Market Cap Chart
Since the IPO on September 4, 2013, OKYO Pharma's market cap has decreased from $141.20M to $82.92M, a decrease of -41.28%. That is a compound annual growth rate of -4.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 82.92M | 6.50% |
| Dec 31, 2025 | 77.85M | 100.10% |
| Dec 31, 2024 | 38.91M | -33.86% |
| Dec 29, 2023 | 58.83M | 38.58% |
| Dec 20, 2022 | 42.45M | -48.55% |
| Dec 10, 2021 | 82.51M | 4.85% |
| Dec 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| eXoZymes | 89.03M |
| Rani Therapeutics Holdings | 86.84M |
| PolyPid | 86.45M |
| Adicet Bio | 85.13M |
| Pelthos Therapeutics | 83.12M |
| Champions Oncology | 82.76M |
| Q32 Bio | 82.66M |
| Gain Therapeutics | 81.95M |